Pharmacotherapy of inflammatory bowel diseases: efficacy performance and safety management

Treatment of inflammatory bowel diseases IBD (Crohns disease, ulcerative colitis) is aimed at achieving clinical, endoscopic and histological remission, minimizing surgical complications, and ensuring a normal quality of life. However, the use of medical treatment is potentially associated with var...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Igor G. Bakulin, Maria I. Skalinskaya, Igor V. Maev, Ekaterina V. Skazyvaeva, Mariia S. Zhuravleva, Larisa B. Gaikovaya, Natalia V. Bakulina, Aleksei I. Ermakov, Ekaterina S. Alekseenko, Kristina N. Ivanova, Mikhail V. Solovev
Formato:	article
Lenguaje:	RU
Publicado:	"Consilium Medicum" Publishing house 2021
Materias:	inflammatory bowel diseases crohn’s disease ulcerative colitis safety of inflammatory bowel diseases therapy efficacy of inflammatory bowel diseases therapy 5-aminosalicylates thiopurines biologic therapy Medicine R
Acceso en línea:	https://doaj.org/article/b1259293af26444085a9d53cbce6157d
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

Pharmacotherapy of inflammatory bowel diseases: efficacy performance and safety management

Ejemplares similares